Literature DB >> 21855346

Importance of Candida-bacterial polymicrobial biofilms in disease.

Melphine M Harriott1, Mairi C Noverr.   

Abstract

Candida albicans is the most prevalent human fungal pathogen, with an ability to inhabit diverse host niches and cause disease in both immunocompetent and immunocompromised individuals. C. albicans also readily forms biofilms on indwelling medical devices and mucosal tissues, which serve as an infectious reservoir that is difficult to eradicate, and can lead to lethal systemic infections. Biofilm formation occurs within a complex milieu of host factors and other members of the human microbiota. Polymicrobial interactions will probably dictate the cellular and biochemical composition of the biofilm, as well as influence clinically relevant outcomes, such as drug and host resistance and virulence. In this manuscript, we review C. albicans infections in the context of in vivo polymicrobial biofilms and implications for pathogenesis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21855346      PMCID: PMC3205277          DOI: 10.1016/j.tim.2011.07.004

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  94 in total

1.  Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.

Authors:  Mairi C Noverr; Nicole R Falkowski; Rod A McDonald; Andrew N McKenzie; Gary B Huffnagle
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  Intrauterine devices and pelvic inflammatory disease: recent developments.

Authors:  D A Grimes
Journal:  Contraception       Date:  1987-07       Impact factor: 3.375

3.  Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation.

Authors:  Melphine M Harriott; Mairi C Noverr
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

4.  Fabrication of a multi-applicable removable intraoral denture system for rodent research.

Authors:  H Lee; A Yu; C C Johnson; E A Lilly; M C Noverr; P L Fidel
Journal:  J Oral Rehabil       Date:  2011-02-17       Impact factor: 3.837

5.  Candida sepsis. Implications of polymicrobial blood-borne infection.

Authors:  D L Dyess; R N Garrison; D E Fry
Journal:  Arch Surg       Date:  1985-03

6.  Pseudomonas-Candida interactions: an ecological role for virulence factors.

Authors:  Deborah A Hogan; Roberto Kolter
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

Review 7.  Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature.

Authors:  Stephen A Klotz; Brian S Chasin; Barbara Powell; Nand K Gaur; Peter N Lipke
Journal:  Diagn Microbiol Infect Dis       Date:  2007-09-20       Impact factor: 2.803

8.  Intrauterine devices and pelvic inflammatory disease: an international perspective.

Authors:  T M Farley; M J Rosenberg; P J Rowe; J H Chen; O Meirik
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

9.  Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut.

Authors:  G Samonis; A Gikas; P Toloudis; S Maraki; G Vrentzos; Y Tselentis; N Tsaparas; G Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

10.  Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections.

Authors:  Raquel Ferraz do Lago; Jose A Simões; Luis Bahamondes; Rodrigo P S Camargo; Marcos Perrotti; Ilza Monteiro
Journal:  Contraception       Date:  2003-08       Impact factor: 3.375

View more
  94 in total

1.  Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.

Authors:  Kaat De Cremer; Ellen Lanckacker; Tanne L Cools; Marijke Bax; Katrijn De Brucker; Paul Cos; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic Candida albicans.

Authors:  Xiaoru Wang; Jianlan You; Jarrod B King; Douglas R Powell; Robert H Cichewicz
Journal:  J Nat Prod       Date:  2012-03-08       Impact factor: 4.050

3.  Cholic Acid-Peptide Conjugates as Potent Antimicrobials against Interkingdom Polymicrobial Biofilms.

Authors:  Siddhi Gupta; Jyoti Thakur; Sanjay Pal; Ragini Gupta; Deepakkumar Mishra; Sandeep Kumar; Kavita Yadav; Amandeep Saini; Prabhu S Yavvari; Madhukar Vedantham; Archana Singh; Aasheesh Srivastava; Rajendra Prasad; Avinash Bajaj
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.

Authors:  Katrijn De Brucker; Nicolas Delattin; Stijn Robijns; Hans Steenackers; Natalie Verstraeten; Bart Landuyt; Walter Luyten; Liliane Schoofs; Barbara Dovgan; Mirjam Fröhlich; Jan Michiels; Jos Vanderleyden; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

5.  Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo.

Authors:  Megan L Falsetta; Marlise I Klein; Punsiri M Colonne; Kathleen Scott-Anne; Stacy Gregoire; Chia-Hua Pai; Mireya Gonzalez-Begne; Gene Watson; Damian J Krysan; William H Bowen; Hyun Koo
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

Review 6.  Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.

Authors:  David S Perlin
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 7.  Fungal biofilms, drug resistance, and recurrent infection.

Authors:  Jigar V Desai; Aaron P Mitchell; David R Andes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

8.  Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.

Authors:  Jianlan You; Lin Du; Jarrod B King; Brian E Hall; Robert H Cichewicz
Journal:  ACS Chem Biol       Date:  2013-02-14       Impact factor: 5.100

Review 9.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 10.  Innate Immunity and Saliva in Candida albicans-mediated Oral Diseases.

Authors:  O Salvatori; S Puri; S Tati; M Edgerton
Journal:  J Dent Res       Date:  2016-01-08       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.